Press Releases
Corbus Pharmaceuticals to Present at the Cystic Fibrosis Workshop Hosted by JMP Securities on May 8, 2015
Corbus Pharmaceuticals Receives $5 Million Development Award From Cystic Fibrosis Foundation Therapeutics to Advance Resunab™ Clinical Program
Corbus Pharmaceuticals Announces Initiation of Trading on The Nasdaq Capital Market
Corbus Pharmaceuticals Announces Uplisting to The NASDAQ Capital Market
Corbus Pharmaceuticals Announces Presentation of Positive Data on Anti-Fibrotic Effects of Resunab™ in a Preclinical Model of Lung Fibrosis at the Experimental Biology 2015 Scientific Conference
Corbus Pharmaceuticals' IND Receives Clearance From FDA to Initiate Phase 2 Trials in Scleroderma With Its Novel Specialized Pro-Resolving Mediator Drug Resunab™
Corbus Pharmaceuticals Observes Annual Rare Disease Day
Corbus Pharmaceuticals to Present at the Leerink Global Healthcare Conference on February 11, 2015
Corbus Pharmaceuticals Reports 2014 Financial Results and Provides 2015 Business Update
Corbus Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference on February 9, 2015
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
Corbus Pharmaceuticals to Present at the Oppenheimer 25th Annual Healthcare Conference on December 10, 2014
Corbus Pharmaceuticals to Present at VirtualInvestorConferences.com Online Event on December 4, 2014
Corbus Pharmaceuticals Reports 2014 Third Quarter Results and Business Update
Corbus Pharmaceuticals Commences Trading on OTCQB under Ticker Symbol CRBP
Corbus Pharmaceuticals to Present at the 13th Annual BIO Investor Forum in San Francisco on Wednesday, October 8, 2014
Corbus Pharmaceuticals to Present at the Leerink Partners Rare Disease Roundtable in New York on Wednesday, October 1, 2014
Corbus Pharmaceuticals to Present at Two Investor Conferences in September
Corbus Pharmaceuticals Observes World Scleroderma Day
Corbus Pharmaceuticals to Present at the 2014 BIO International Convention
Corbus Pharmaceuticals Completes $10.3 Million Private Placement
